Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Arbeitsgemeinschaft medikamentoese Tumortherapie"
Count: 44
Selected: 0
NCT03984214Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
NCT02891811Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy
NCT04438889Austrian Myeloid Registry
NCT01595295Registry on Hypomethylating Agents in Myeloid Neoplasms
NCT06294652AGMT Austrian Lymphoma Registry
NCT04654364Lung Cancer Registry
NCT03870620Metastatic Breast Cancer in Austria
NCT03301493Genomic Testing and Resulting Medical Decisions
NCT06250465AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
NCT04891809Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM
NCT03792763Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients
NCT01884259Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
NCT02462538Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL
NCT00951457Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
NCT02987400Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL
NCT01703390Biomarker Directed Treatment in Metastatic Colorectal Cancer
NCT04351529Austrian COVID-19 Registry
NCT02993094Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
NCT00952003Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
NCT02236936Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck
NCT01118234Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
NCT02410694Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT01933906Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response
NCT01891227Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer
NCT01560117Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma
NCT00565981A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response
NCT01611259Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue
NCT02097108Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir
NCT01703364Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
NCT00400478A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
NCT01384838Exercise Training in Postmenopausal Patients With Breast Cancer
NCT01579357Pharmacokinetics and Metabolic Activation of Capecitabine
NCT01368757Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
NCT00735345Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
NCT00972842Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)
NCT00903656Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
NCT00656812Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
NCT01368848Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
NCT00738829Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
NCT00575406Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
NCT01351038Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma
NCT00517894Dose-Dense Therapy in Aggressive Lymphoma
NCT03948035Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
NCT05798156Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP